(Q37681565)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Pharmacotherapy of major depressive disorder in adolescents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

major depressive disorder

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Francesca Liboni

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Paola Brovedani

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

375-386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Age effects on antidepressant-induced manic conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

The clinical phenotypes of juvenile bipolar disorder: toward a validation of the episodic-chronic-distinction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Clinical implications of DSM-IV subtyping of bipolar disorders in referred children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Effects of psychotherapy for depression in children and adolescents: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Adverse life events and resilience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Cognitive behavioral therapy for depression in youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Treatment for Adolescents with Depression Study (TADS): safety results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Treated depression in adolescents: predictors of outcome at 28 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Efficacy of antidepressants in juvenile depression: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Clinical messages from the Treatment for Adolescents With Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

The prevalence of suicidal phenomena in adolescents: a systematic review of population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Suicidal events in the Treatment for Adolescents With Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

Depressed Adolescents Grown Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903527226

10.1517/14656560903527226

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102303%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference